IgNS

IgNS has been a member of Linktree for 4 years and joined in April 2022. The social media accounts linked to from IgNS are: • Facebook • Instagram • LinkedIn • Email • X Besides social media accounts, ignsorg has populated their site with: • IgNS and ACHC Launch New Distinction to Elevate Standards • Secondary Immunodeficiency: A Growing Healthcare Concern • Restoring Immune Homeostasis In Long COVID • Registration Still Open: 2026 Patient 360 On-Demand • Recombinant Human Hyaluronidase PH20 in Biologics and Immunoglobulin Therapy: Clinical Applications • 2025 Specialty Pharmacy Continuum Special Edition • IgNS 2026 National Conference - Register Now! • IgNS 2026 Sponsor & Exhibitor Interest Form • IgNS on SamaCare’s The Road to Care Podcast: Advancing Standards in Ig Therapy • View All IgCN®/IgCP® Certification Exam Windows • Fundamentals of Subcutaneous Immunoglobulin Therapy • IgNS 2026 Prospectus • Immunoglobulin Therapy Aseptic Meningitis Syndrome • Apply for a First-Time Attendee Scholarship • Register for an IgCN®/IgCP® Exam • Immunologic and Anaphylactoid Reactions in Ig Therapy • Webinar: Clinical Updates in the Management of CIDP • Patient Guide to Immunoglobulin Therapy • Submit an Abstract for IgNS 2026 • It's My Turn - Donate Plasma • Patient Experience Survey • IgNS Website • Biosimilars Survey • IgNS 2025 Call for Topics • Press Release: IgNS Appoints Amy E. Clarke, DNP, RN, IgCN®, as Chief Clinical Officer • IgNS 2024 13th National Conference • Ig Therapy Standards of Practice (Version 3.2) • IgNS Product & Risk Factors Chart • CE/CME Webinar Programs